Randomized trial assesses biocompatibility and performance of a biodegradable alloy in orthopedic fixation, highlighting its clinical implications.
of ∼245.0 MPa, and ε of ∼33.5%, with minimal strength/ductility loss after 30-day immersion in Hanks' Balanced Salt Solution (HBSS). It demonstrates a favorable electrochemical corrosion rate (∼162 µm/y), degradation rate (∼20.1 µm/y), and superior biotribological resistance in Dulbecco's Modified Eagle Medium supplemented with fetal bovine serum (DMEM+FBS). Biologically, it enhances osteoblast viability and mineralization while providing near-complete S. aureus antibacterial efficacy in vitro and in vivo. This synergistic combination of strength, corrosion-wear resistance, and bioactivity highlights the alloy's significant potential for advanced biodegradable orthopedic applications.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: